Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε- caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer

Journal of Biomaterials Science, Polymer Edition

Volumn 22, Issue 11, 2011, Pages 1409-1426

  Cuong, Nguyen Van ^a   Hsieh, Ming Fa ^a   Chen, Yung Tsung ^a   Liau, Ian ^b  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

doxorubicin; micelles; multidrug resistance; poly(ethyl ethylene phosphate); poly( caprolactone); Star shaped co polymer

Indexed keywords

CONTROLLED DRUG DELIVERY; ETHYLENE; NITRIC OXIDE; POLYMERS; STARS; TARGETED DRUG DELIVERY;

CAPROLACTONE; DOXORUBICIN; HUMAN BREAST CANCER; LOADING EFFICIENCY; MULTIDRUG RESISTANCE; PHOSPHATE MONOMERS; POLY (EPSILONCAPROLACTONE); POLY(ETHYL ETHYLENE PHOSPHATE);

MICELLES;

COPOLYMER; DOXORUBICIN; NITRIC OXIDE; POLYCAPROLACTONE;

AQUEOUS SOLUTION; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG SENSITIVITY; DRUG SYNTHESIS; ENCAPSULATION; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; INCUBATION TEMPERATURE; MICELLE; PH; PRIORITY JOURNAL;

EID: 79953691612     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050610X510533     Document Type: Article

References (41)

1. A. K. Sharma, L. Zhang, S. Li, D. L. Kelly, V. Y. Alakhov, E. V. Batrakova and A. V. Kabanov, J. Control. Rel. 131, 220 (2008).
2. G. Kwon, S. Suwa, M. Yokoyama, T. Okano, Y. Sakurai and K. Kataoka, J. Control. Rel. 29, 17 (1994).
3. G. S. Kwon and T. Okano, Adv. Drug Deliv. Rev. 21, 107 (1996).
4. S. Chen, X. Z. Zhang, S. X. Cheng, R. X. Zhuo and Z.W. Gu, Biomacromolecules 9, 2578 (2008).
5. K. Kono, C. Kojima, N. Hayashi, E. Nishisaka, K. Kiura, S. Watarai and A. Harada, Biomaterials 29, 1664 (2008).
6. F. Wang, T. K. Bronich, A. V. Kabanov, R. D. Rauh and J. Roovers, Bioconjug. Chem. 19, 1423 (2008).
7. J. Panyam and V. Labhasetwar, Adv. Drug Deliv. Rev. 55, 329 (2003).
8. C. Shen, S. Guo and C. Lu, Polym. Degrad. Stabil. 92, 1891 (2007).
9. H. Otsuka, Y. Nagasaki and K. Kataoka, Adv. Drug Deliv. Rev. 55, 403 (2003).
10. Y. C.Wang, L. Y. Tang, T. M. Sun, C. H. Li, M. H. Xiong and J.Wang, Biomacromolecules 9, 388 (2008).
11. Z. Zhao, J. Wang, H. Q. Mao and K. W. Leong, Adv. Drug Deliv. Rev. 55, 483 (2003).
12. T. Maria and H. Clifford, Cancer 100, 2052 (2004).
13. J. Cui, C. Li, W. Guo, Y. Li, C. Wang, L. Zhang, L. Zhang, Y. Hao and Y. Wang, J. Control. Rel. 118, 204 (2007).
14. R. Krishna and L. D. Mayer, Eur. J. Pharm. Sci. 11, 265 (2000).
15. N. Marchi, K. Hallene, K. Kight, L. Cucullo, G. Moddel, W. Bingaman, G. Dini, A. Vezzani and D. Janigro, BMC Med. 2, 37 (2004).
16. N. Cao and S. S. Feng, Biomaterials 29, 3856 (2008).
17. M. F. Hsieh, N. V. Cuong, C. H. Chen, Y. T. Chen and J. M. Yeh, J. Nanosci. Nanotechnol. 8, 2362 (2008).
18. J. Wen, G. J. A. Kim and K. W. Leong, J. Control. Rel. 92, 39 (2003).
19. C. Lu, S. Guo, L. Liu, Y. Zhang, Z. Li and J. Gu, J. Polym. Sci. Polym. Phys. 44, 3406 (2006).
20. H. M. Aliabadi, A. Mahmud, A. D. Sharifabadi and A. Lavasanifar, J. Control. Rel. 104, 301 (2005).
21. X. Shuai, H. Ai, N. Nasongkla, S. Kim and J. Gao, J. Control. Rel. 98, 415 (2004).
22. Standard Practice for Assessment of Hemolytic Properties of Materials. ASTM International, West Conshohocken, PA (2000).
23. A. Finne and A.-C. Albertsson, Biomacromolecules 3, 684 (2002).
24. J. Choi, I. K. Kim and S. Y. Kwak, Polymer 46, 9725 (2005).
25. J. Zhang, L. Q. Wang, H. Wang and K. Tu, Biomacromolecules 7, 2492 (2006).
26. J. Cheng, J. X. Ding, Y. C. Wang and J. Wang, Polymer 49, 4784 (2008).
27. Y. Zhang and R. X. Zhuo, Biomaterials 26, 6736 (2005).
28. K. E. Schmalenberg, L. Frauchiger, L. Nikkhouy-Albers and K. E. Uhrich, Biomacromolecules 2, 851 (2001).
29. C. L. Peng, M. J. Shieh, M. H. Tsai, C. C. Chang and P. S. Lai, Biomaterials 29, 3599 (2008).
30. E. J. Park and K. Park, Toxicol. Lett. 184, 18 (2009).
31. C. Allen, D. Maysinger and A. Eisenberg, Colloids Surfaces B: Biointerfaces 16, 3 (1999).
32. M. Prabaharan, J. J. Grailer, S. Pilla, D. A. Steeber and S. Gong, Biomaterials 30, 3009 (2009).
33. C. W. Yde, M. P. Clausen, M. V. Bennetzen, A. E. Lykkesfeldt, O. G. Mouritsen and B. Guerra, Anti-Cancer Drugs 20, 723 (2009).
34. M. D. Chavanpatil, Y. Patil and J. Panyam, Int. J. Pharm. 320, 150 (2006).
35. C. Chun, S. M. Lee, C. W. Kim, K. Y. Hong, S. Y. Kim, H. K. Yang and S. C. Song, Biomaterials 30, 4752 (2009).
36. F. Q. Hu, L. N. Liu, Y. Z. Du and H. Yuan, Biomaterials 30, 6955 (2009).
37. S. Q. Liu, N. Wiradharma, S. J. Gao, Y. W. Tong and Y. Y. Yang, Biomaterials 28, 1423 (2007).
38. Z. Zhang, S. Huey Lee and S. S. Feng, Biomaterials 28, 1889 (2007).
39. C. L. Lo, S. J. Lin, H. C. Tsai,W. H. Chan, C. H. Tsai, C. H. D. Cheng and G. H. Hsiue, Biomaterials 30, 3961 (2009).
40. Y. Yi, J. H. Kim, H.-W. Kang, H. S. Oh, S. W. Kimand M. H. Seo, Pharm. Res. 22, 200 (2005).
41. H. Zhao and L. Y. L. Yung, Int. J. Pharm. 349, 256 (2008).